Antimicrobial Resistance and Novel Therapeutics in Critical Care Medicine

The International Journal of Clinical Pharmacy and Medicine (IJCPM) invites submissions focused on Antimicrobial Resistance and Novel Therapeutics in Critical Care Medicine.

We welcome original research, reviews, clinical studies, case series, and quality improvement reports addressing the management of multidrug-resistant infections in critically ill patients.

Topics of interest include emerging resistance mechanisms, antimicrobial stewardship, rapid diagnostics, optimization of antimicrobial dosing, combination therapy, novel antibiotics, bacteriophage therapy, antimicrobial pharmacokinetics and pharmacodynamics, therapeutic drug monitoring, and treatment strategies for resistant Gram-negative and Gram-positive infections.

Submissions that provide practical insights into improving antimicrobial effectiveness, reducing toxicity, and supporting evidence-based treatment of severe infections in intensive care settings are particularly encouraged.

IJCPM welcomes contributions from pharmacists, intensivists, infectious diseases specialists, microbiologists, researchers, and multidisciplinary critical care teams worldwide.